We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Interoperability Growing Despite Lack of Incentives

Interoperability Growing Despite Lack of Incentives

May 29, 2015

Governments and standards organizations worldwide are moving toward a healthcare delivery system where devices work together, but devicemakers may need better incentives to get on board, an analyst says.

Shruthi Parakkal, a senior research analyst with Frost & Sullivan, says governments in the U.S., EU and other jurisdictions have been encouraging interoperability by issuing standards and guidance documents. “It’s not that the standards have not been set. It’s that they have not been utilized to the proper level due to a lack of incentives,” she says.

Governments will need to step in with regulations before interoperability among medical devices becomes routine, because it’s not always clear to companies what the benefits are, Parakkal told IDDM. Devicemakers typically use proprietary technology that blocks their devices from communicating with other products, and they often lack the expertise or willingness to change, she adds.

Factors preventing the design of interoperable devices include:

  • A perception that the devicemaker is primarily a software developer and can better spend R&D funds on other efforts;
  • Reluctance to involve the FDA or other regulatory authorities;
  • The lack of a strong industry culture of interoperability, such as is found in aerospace; and
  • The need to invest in fast-changing new technologies like WiFi and Bluetooth to maintain interoperability.

Meanwhile, hospitals and caregivers want devices that talk to one another, but are often constrained by cost considerations and lack of in-house expertise, says Parakkal, who authored a recent Frost & Sullivan report on healthcare and medical device connectivity and interoperability. To get around those issues, many opt for third-party connectivity that is vendor-neutral. An example is a software vendor that designs products allowing devices used in hospitals to feed into a common medical record system.
— Elizabeth Orr

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • AstraZeneca

    AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

  • CE mark

    Cue Health’s COVID-19 Test Receives CE Mark

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing